Book Navigation

We are sorry, but signing in with LinkedIn is not possible at this time.



This G-I-N award acknowledges an individual’s contribution to innovation in the methodology, development, and /or implementation of clinical practice guidelines.

Najoua Mlika-Cabanne October 2008

Najoua Mlika-Cabanne


The Najoua Mlika-Cabanne Innovation Award is named in memory of Najoua Mlika-Cabanne MD PHD, formerly Deputy Head of the Guidelines Department at the Haute Autorité de Santé (HAS, French National Authority for Health), Trustee of the Guidelines International Network between 2003 and 2010, and G-I-N Honorary Patron

Najoua Mlika-Cabanne graduated in medicine from Sousse Medical Faculty in Tunisia in 1982. From a local government post in public health in Tunisia, Najoua moved to clinical research in France first at the Gustave Roussy Cancer Centre and then at INSERM, the French National Institute for Health and Medical Research. After that Najoua became deputy head of the Guidelines Department at the Haute Autorité de Santé (HAS, French National Authority for Health). She was in charge of various aspects of the development of clinical practice guidelines for over 10 years: drafting of guidelines, managing a team of guideline developers, and university teaching, in particular courses on medical statistics, quality management, and assessment of health systems. In her post at HAS, she liaised with experts in a very wide variety of aspects of the development of quality of care and health technology assessment.

From 2000, Najoua was increasingly involved in national and international partnerships. She was on the Committee for the Assessment of National Registers at the French Institute for Public Health Surveillance (InVS), was the mandated HAS representative for several collaborative international projects (for example, CoCanCPG), and was an active member of the International Review Panel of the International Society for Quality in Healthcare (ISQUA), the ADAPTE collaboration, and G-I-N.

Najoua was elected to the G-I-N Board in 2003 and was co-chair of the international Working Group on Evidence Tables. She was also a co-editor of enGINe, the G-I-N newsletter.

During her career Dr Najoua Mlika-Cabanne made a significant contribution to the science of clinical guideline development and consistently fostered international collaboration and friendship.   

Previous Award Recipients

Fifth award 2017

Linn Brandt2

Dr Linn Brandt







Fourth award 2016

Richard Rosenfeld

Ilkka Kunnamo










Third Award 2015

 Philip van der Wees

 Philip van der Wees


Second award 2014

Jeremy Grimshaw


 First award 2012

  Marcia Kelson and NMC Award

Marcia Kelson


Robin Vernooij

Award Recipient      2018 -

Robin Vernooij


Robin Vernooij is currently guidelines consultant and information specialist at the Netherlands Comprehensive Cancer Organisation (IKNL). In this position he has been responsible for constructing evidence profiles of different clinical practice guidelines (CPGs) regarding the diagnosis and treatment of cancer patients in the Netherlands. As part of this role he has been both responsible for ensuring a good quality evidence-based methodology in the Dutch oncology CPGs and advise the members of the guideline working group. Robin is involved in IKNL guideline innovation projects regarding the development of guideline flow-charts and information standards. He is also participating in collaboration with international partners to improve usage of resources and efficiency in guideline development among different countries to reduce research waste.

Robin, as an epidemiologist, has an extensive education and experience in systematic reviews as he worked for the Cochrane collaboration between 2012 and 2015 and still continues to work (on-distance) for the dementia and diagnostic test accuracy group of Cochrane. Aside from the extensive work regarding systematic reviews, in the lberoamerican Cochrane Centre in Barcelona Robin took part in the construction of CPGs of the Spanish national health system and the Pan American Health Organisation.

In 2013, Robin started a PhD programme at the Autonomous University of Barcelona with the subject of "Updating CPGs: Development of an instrument to assess the reporting of the updating process in updated CPGs". This programme is expected to be finished at the end of 2016. His thesis consists of developing an instrument (UpCheck) which allows assessing the reporting of the updating process in updated CPGs. This project is a collaboration between the G-I-N Updating group, McMaster university and the lberoamerican Cochrane Centre.

Robin has a special interest in the methodology of updating CPGs. In this matter, he conducted different studies regarding updating including the guidance reported in methodological handbooks of guideline institutions and the efficacy of pragmatic search strategies. The UpCheck instrument is a first attempt to improve the updating process of CPGs. Research regarding the development of de nova CPGs is rather extensive and there is still a long way to go to reach the same level for the updating part of CPGs. Robin is contributing to the development of a golden standard for the updating process. Similarly, the implementation of guidelines is another field of interest of Robin. In the last years, together with members of the G-I-N Implementation group, Robin explored patient­ oriented tools to support self-management in CPGs and questionnaires used to assess barriers of guideline implementation. This has been done by taking part of several (research) initiatives regarding methodology, guidelines, and systematic reviews, including the GRADE working group, the G-I-N updating group, and the G-I-N implementation group.

In the upcoming year, Robin will continue his work to improve the guideline venture in the Netherlands and pursue searching for better methodologies and advances in the methodology to develop, update, present, and implement CPGs.


May 2019
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31
Page last updated: Jan 18, 2019
Back to top